imiquimod has been researched along with Parakeratosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, M; Fujisawa, Y; Furuta, J; Inoue, S; Ishitsuka, Y; Nakamura, Y; Ogawa, T; Okiyama, N; Saito, A; Watanabe, R | 1 |
| Asselbergh, B; De Rycke, R; Declercq, W; Deforce, D; Denecker, G; Gilbert, B; Hachem, JP; Hoste, E; Prens, EP; van der Fits, L; Van Nieuwerburgh, F; Vandenabeele, P | 1 |
2 other study(ies) available for imiquimod and Parakeratosis
| Article | Year |
|---|---|
Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Regulates Epidermal Keratinization under Psoriatic Skin Inflammation.
Topics: Animals; Cell Differentiation; Cells, Cultured; Chimera; Epidermis; Female; Homeostasis; Humans; Imiquimod; Immunohistochemistry; Inflammation; Keratinocytes; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2; Parakeratosis; Psoriasis; Skin | 2020 |
Caspase-14-deficient mice are more prone to the development of parakeratosis.
Topics: Aminoquinolines; Animals; Caspases; Cell Differentiation; Cell Proliferation; Disease Models, Animal; Genetic Predisposition to Disease; Imiquimod; Keratinocytes; Mice; Mice, Knockout; Parakeratosis; Psoriasis | 2013 |